Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADAMTS-like protein 4 is a secreted glycoprotein encoded by the ADAMTSL4 gene in humans. It is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs)-like gene family and is structurally distinct from enzymatically active ADAMTS proteases in that it lacks a catalytic domain. ADAMTSL4 contains seven thrombospondin type 1 repeats, domains found in proteins that regulate diverse biological processes such as cellular adhesion, angiogenesis, and developmental patterning of the nervous system. Mutations in ADAMTSL4 are associated with disorders such as isolated ectopia lentis, characterized by displacement of the eye lens[1][2]. ADAMTS-like proteins do not have demonstrated enzymatic activity and are primarily implicated in the formation and maintenance of the extracellular matrix rather than serving as direct drug targets or therapeutic receptors[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADAMTS-like protein 4 (ADAMTSL4).